Correction Notice: Inaccurate Data in COVID-19 Vaccination Study
Overview
This correction notice addresses an error in the vaccine effectiveness 95% confidence interval (CI) reported in a previous study on COVID-19 vaccination and transmission risk. The corrected CI for primary case participants at 6 months or less since vaccination is now stated as 7% to 65%.
Background
Accurate reporting of vaccine effectiveness is crucial for understanding the impact of COVID-19 vaccinations on transmission rates.
Data Highlights
No numerical data table is provided in the correction notice.
Key Findings
- The original study reported an incorrect 95% CI for vaccine effectiveness.
- The corrected 95% CI for primary case participants at 6 months or less is 7% to 65%.
Clinical Implications
Healthcare professionals should remain aware of corrections in published studies to ensure informed decision-making. Continuous monitoring of vaccine effectiveness data is essential for guiding vaccination strategies.
Conclusion
This correction serves as a reminder of the need for accuracy in clinical research reporting, particularly regarding vaccine effectiveness.
Related Resources & Content
- JAMA Network Open, 2026 -- Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission
- Drug Safety, 2022 -- Erratum: Evaluating Case Fatality Rates in Thrombosis with Concurrent Thrombocytopenia Post COVID-19 AstraZeneca Vaccination
- BMC Infectious Diseases, 2026 -- Correction: Pneumococcal vaccine for prevention of acute otitis media in children: a meta-analysis
- Bone Marrow Transplantation -- Erratum: Factors Influencing Vaccine Efficacy in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
- CDC, 2025-2026 -- 2025–2026 COVID-19 Vaccination Guidance
- Open Forum Infectious Diseases — Correction to: Comparative Immunogenicity and Safety of Higher-Valent Pneumococcal Conjugate Vaccines Versus the 13-Valent Version in Elderly Populations: A Systematic Review and Meta-Analysis of Randomized Trials
- 2025–2026 COVID-19 Vaccination Guidance | Covid | CDC
- Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission
- MMWR Weekly / Vol. 74 / No. 6
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
